However, emerging evidence suggests a potential link between GLP-1 therapy and altered pain perception, possibly through several mechanisms: 1- Neuroinflammation and Microglial Activation: GLP-1 receptors are expressed in the brainstem, spinal cord, and dorsal root ganglia, regions involved in pain modulation
The FDA Has Explicitly Rejected Cost as a Justification In its April 2026 proposal, the FDA explicitly rejected affordability and insurance access as constituting clinical need for continued bulk compounding
"ATTAINMAINTAIN showed that orforglipron, a once-daily oral GLP-1, helped people maintain the weight they worked hard to lose." This data provides the first robust, Phase 3 evidence that an oral "step-down" or "switch" strategy is not just feasible but effective, offering a new pathway for the long-term management of obesity
& Garca-Foncillas, J
While balancing vitamin and mineral levels with supplementation may help with some weight loss, it is rarely the only cause of excess weight gain